Growing concern about the climate has seen a four-fold increase in carbon off-setting over the past 18 months - are hospitals seeing a "Greta effect" too?
A specialist developer is planning to turn an underground carpark under a central London park near Harley Street into a four-storey subterranean healthcare and wellness development. Provisional talks with private hospital and diagnostic operators have been held, while wellness and leisure operators could be housed under the same roof. HBI talks exclusively to the team at Reef Group and its partners about the plan to transform historic Cavendish Square.
HBI understands that a majority stake is being sold by a fast-growing UK-based dental chain to a European PE fund. We name the group, buyer, price and multiple, and speak to a market expert about the deal.
This week we look at homecare companies which have been held longer than the usual private equity cycle (some by a large margin) and ask: which are most likely to sell?
Canada's largest single-profession pension fund has become the lead investor in the KRY's €140m Series C funding round. HBI speculates on the investment, the valuation and future plans of Europe's largest digital health player.
UK hospital group Circle Health is acquiring competitor BMI Healthcare, confirming HBI's earlier exclusive report, while international healthcare REIT Medical Properties Trust (MPT) is buying the bulk of the real estate. We talk to UK advisors and crunch the numbers of the deal.
HBI hears ophthalmic specialist SpaMedica, the largest UK NHS cataract surgery provider, is back up for sale just two months after it was pulled from the market. HBI speaks to a UK based market expert to find out more, and about how the group continues to carve out a growing niche for itself, and speculates on price and multiple.
Advisors tell HBI that US-listed group Acadia's sale of UK psychiatry provider The Priory is certain to go ahead this quarter - with investment memorandums (IMs) possibly out in the next few weeks.
London-listed UAE-based NMC Health, which saw its share price plummet after research firm Muddy Waters published a negative report last week, has announced an independent review into "assertions made by certain third parties". Its share price partially recovered at the news.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
